Evidence map

ArticleHypertension research : official journal of the Japanese Society of Hypertension2024

Will esaxerenone be added to the antihypertensive treatment strategy of practicing physicians as a second-line antihypertensive drug?

Tetsuro YoshidaPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39232192